-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
BridgeBio Pharma, Inc. quarterly/annual Operating Margin history and growth rate from 2019 to Q3 2025.
- BridgeBio Pharma, Inc. Operating Margin for the quarter ending September 30, 2025 was -172 %, a 31% increase year-over-year.
- BridgeBio Pharma, Inc. annual Operating Margin for 2024 was -267 %, a 95.9% increase from 2023.
- BridgeBio Pharma, Inc. annual Operating Margin for 2023 was -6.53K %, a 890% decline from 2022.
- BridgeBio Pharma, Inc. annual Operating Margin for 2022 was -660 %, a 20.2% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)